Epidemiology, susceptibility, and risk factors for acquisition of MDR/XDR Gram-negative bacteria among kidney transplant recipients with urinary tract infections

References

• Leylabadlo HE, Kafil HS, Yousefi M, Aghazadeh M, Asgharzadeh M. Persistent infection with metallo-beta-lactamase and extended spectrum β-lactamase producer Morganella morganii in a patient with urinary tract infection after kidney transplantation. J Nat Sci Biol Med. 2016;7(2):179–181.
   PubMedGoogle Scholar
• Yabanoğlu H, Alışkan HE, Çalışkan K, et al. Early infections in renal transplant recipients: incidence, risk factors, and causative microorganisms. Exp Clin Transplant. 2015;13 Suppl 3:11–14.
   Google Scholar
• Espinar MJ, Miranda IM, Costa-de-Oliveira S, et al. Urinary tract infections in kidney transplant patients due to Escherichia coli and Klebsiella pneumoniae-producing extended-spectrum β-lactamases: risk factors and molecular epidemiology. PLoS One. 2015;10(8):e0134737.
   PubMed Web of Science ®Google Scholar
• Pilmis B, Scemla A, Join-Lambert O, et al. ESBL-producing enterobacteriaceae-related urinary tract infections in kidney transplant recipients: incidence and risk factors for recurrence. Infect Dis (Lond). 2015;47(10):714–718.
   PubMed Web of Science ®Google Scholar
• Silva M Jr, Marra AR, Pereira CA, Medina-Pestana JO, Camargo LF. Bloodstream infection after kidney transplantation: epidemiology, microbiology, associated risk factors, and outcome. Transplantation. 2010;90(5):581–587.
   PubMed Web of Science ®Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281.
   PubMed Web of Science ®Google Scholar
• Bodro M, Sanclemente G, Lipperheide I, et al. Impact of antibiotic resistance on the development of recurrent and relapsing symptomatic urinary tract infection in kidney recipients. Am J Transplant. 2015;15(4):1021–1027.
   PubMed Web of Science ®Google Scholar
• Origüen J, Fernández-Ruiz M, López-Medrano F, et al. Progressive increase of resistance in Enterobacteriaceae urinary isolates from kidney transplant recipients over the past decade: narrowing of the therapeutic options. Transpl Infect Dis. 2016;18(4):575–584.
   PubMed Web of Science ®Google Scholar
• Silva C, Afonso N, Macario F, Alves R, Mota A. Recurrent urinary tract infections in kidney transplant recipients. Transplant Proc. 2013;45(3):1092–1095.
   Google Scholar
• Gołębiewska J, Tarasewicz A, Dębska-Ślizień A, Rutkowski B. Klebsiella spp urinary tract infections during first year after renal transplantation. Transplant Proc. 2014;46(8):2748–2751.
   PubMed Web of Science ®Google Scholar
• Wan Q, Ye Q, Zhou J. Mortality predictors of bloodstream infections in solid-organ transplant recipients. Exp Clin Transplant. 2013; 11(3):211–214.
   PubMed Web of Science ®Google Scholar
• Lee SO, Kang SH, Abdel-Massih RC, Brown RA, Razonable RR. Spectrum of early-onset and late-onset bacteremias after liver transplantation: implications for management. Liver Transpl. 2011;17(6):733–741.
   PubMed Web of Science ®Google Scholar
• Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med. 2003;29(4):530–538.
   Google Scholar
• Lim JH, Cho JH, Lee JH, et al. Risk factors for recurrent urinary tract infection in kidney transplant recipients. Transplant Proc. 2013;45(4):1584–1589.
   PubMed Web of Science ®Google Scholar
• Kotagiri P, Chembolli D, Ryan J, Hughes PD, Toussaint ND. Urinary tract infections in the first year post-kidney transplantation: potential benefits of treating asymptomatic bacteriuria. Transplant Proc. 2017;49(9):2070–2075.
   PubMed Web of Science ®Google Scholar
• Lee JR, Bang H, Dadhania D, et al. Independent risk factors for urinary tract infection and for subsequent bacteremia or acute cellular rejection: a single-center report of 1166 kidney allograft recipients. Transplantation. 2013;96(8):732–738.
   PubMed Web of Science ®Google Scholar
• Gozdowska J, Czerwinska M, Chabros L, et al. Urinary tract infections in kidney transplant recipients hospitalized at a transplantation and nephrology ward: 1-year follow-up. Transplant Proc. 2016;48(5):1580–1589.
   PubMed Web of Science ®Google Scholar
• Kosmadakis G, Daikos GL, Pavlopoulou ID, et al. Infectious complications in the first year post renal transplantation. Transplant Proc. 2013;45(4):1579–1583.
   PubMed Web of Science ®Google Scholar
• Chuang P, Parikh CR, Langone A. Urinary tract infections after renal transplantation: a retrospective review at two US transplant centers. Clin Transplant. 2005;19(2):230–235.
   PubMed Web of Science ®Google Scholar
• Naik AS, Dharnidharka VR, Schnitzler MA, et al. Clinical and economic consequences of first-year urinary tract infections, sepsis and pneumonia in contemporary kidney transplantation practice. Transpl Int. 2016;29(2):241–252.
   PubMed Web of Science ®Google Scholar
• Lim TP, Lee W, Tan TY, et al. Effective antibiotics in combination against extreme drug-resistant Pseudomonas aeruginosa with decreased susceptibility to polymyxin B. PLoS One. 2011;6(12):e28177.
   PubMed Web of Science ®Google Scholar
• Shields RK, Kwak EJ, Potoski BA, et al. High mortality rates among solid organ transplant recipients infected with extensively drug-resistant Acinetobacter baumannii: using in vitro antibiotic combination testing to identify the combination of a carbapenem and colistin as an effective treatment regimen. Diagn Microbiol Infect Dis. 2011;70(2):246–252.
   PubMed Web of Science ®Google Scholar
• Shields RK, Clancy CJ, Gillis LM, et al. Epidemiology, clinical characteristics and outcomes of extensively drug-resistant Acinetobacterbaumannii infections among solid organ transplant recipients. PLoS One. 2012;7(12): e52349.
   PubMed Web of Science ®Google Scholar
• Metan G, Pala Ç, Kaynar L, Cevahir F, Alp E. A nightmare for haematology clinics: extensively drug-resistant (XDR) Acinetobacter baumannii. Infez Med. 2014;22(4):277–282.
   PubMedGoogle Scholar
• Bader MS, Loeb M, Brooks AA. An update on the management of urinary tract infections in the era of antimicrobial resistance. Postgrad Med. 2017;129(2):242–258.
   PubMed Web of Science ®Google Scholar
• Fiorante S, Fernández-Ruiz M, López-Medrano F, et al. Acute graft pyelonephritis in renal transplant recipients: incidence, risk factors and long-term outcome. Nephrol Dial Transplant. 2011;26(3):1065–1073.
   PubMed Web of Science ®Google Scholar
• Giral M, Pascuariello G, Karam G, et al. Acute graft pyelonephritis and long-term kidney allograft outcome. Kidney Int. 2002;61(5):1880–1886.
   PubMed Web of Science ®Google Scholar
• Ariza-Heredia EJ, Beam EN, Lesnick TG, et al. Urinary tract infections in kidney transplant recipients: role of gender, urologic abnormalities, and antimicrobial prophylaxis. Ann Transplant. 2013;18:195–204.
   PubMed Web of Science ®Google Scholar
• Sorto R, Irizar SS, Delgadillo G, et al. Risk factors for urinary tract infections during the first year after kidney transplantation. Transplant Proc. 2010;42(1):280–281.
   PubMed Web of Science ®Google Scholar
• Pinheiro HS, Mituiassu AM, Carminatti M, Braga AM, Bastos MG. Urinary tract infection caused by extended spectrum beta-lactamase-producing bacteria in kidney transplant patients. Transplant Proc. 2010;42(2):486–487.
   PubMed Web of Science ®Google Scholar
• Linares L, Cervera C, Cofán F, et al. Risk factors for infection with extended-spectrum and AmpC beta-lactamase-producing gram-negative rods in renal transplantation. Am J Transplant. 2008;8(5):1000–1005.
   PubMed Web of Science ®Google Scholar
• Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ. 2010; 340:c2096.
   PubMed Web of Science ®Google Scholar
• Johnson LE, D’Agata EM, Paterson DL, et al. Pseudomonas aeruginosa bacteremia over a 10-year period: multidrug resistance and outcomes in transplant recipients. Transpl Infect Dis. 2009;11(3):227–234.
   PubMed Web of Science ®Google Scholar
• Bodro M, Sabé N, Tubau F, et al. Extensively drug-resistant Pseudomonas aeruginosa bacteremia in solid organ transplant recipients. Transplantation. 2015;99(3):616–622.
   PubMed Web of Science ®Google Scholar
• Munoz P. Management of urinary tract infections and lymphocele in renal transplant recipients. Clin Infect Dis. 2001;33 Suppl 1:S53–57.
   Google Scholar
• Wu SW, Liu KS, Lin CK, et al. Community-acquired urinary tract infection in kidney transplantation: risk factors for bacteremia and recurrent infection. J Formos Med Assoc. 2013;112(3):138–143.
   PubMed Web of Science ®Google Scholar
• Gołębiewska JE, Dębska-Ślizień A, Rutkowski B. Urinary tract infections during the first year after renal transplantation: one center’s experience and a review of the literature. Clin Transplant. 2014;28(11):1263–1270.
   PubMed Web of Science ®Google Scholar
• Cervera C, van Delden C, Gavaldà J, et al. Multidrug-resistant bacteria in solid organ transplant recipients. Clin Microbiol Infect. 2014;20 Suppl 7:49–73.
   Google Scholar
• Sganga G, Spanu T, Bianco G, et al. Bacterial bloodstream infections in liver transplantation: Etiologic agents and antimicrobial susceptibility profiles. Transplant Proc. 2012;44(7):1973–1976.
   PubMed Web of Science ®Google Scholar